Loading…

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

meRfi® AI Chat

NCT03893422 - Bifidobacterium longum infantis + Clostridium beijerinckii + Clostridium butyricum + Inulin-type fructans (ITF) / Inulin vs Akkermansia muciniphila + Anaerobutyricum hallii + Bifidobacterium longum infantis + Clostridium beijerinckii + Clostridium butyricum + Inulin-type fructans (ITF) / Inulin & Type 2 Diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background

There is an increasing amount of evidence indicating that certain naturally occurring gut bacteria are less prevalent in the intestines of individuals with type 2 diabetes (T2D). These bacteria play crucial roles in maintaining gut barrier stability and producing butyrate, both of which are important for regulating glucose and insulin levels (1).

Study overview

NCT03893422 - Bifidobacterium longum infantis + Clostridium beijerinckii + Clostridium butyricum + Inulin-type fructans (ITF) / Inulin vs Akkermansia muciniphila + Anaerobutyricum hallii + Bifidobacterium longum infantis + Clostridium beijerinckii + Clostridium butyricum + Inulin-type fructans (ITF) / Inulin & Type 2 Diabetes (…

References (Sources)

Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation
Perraudeau et al. 2020 BMJ Open Diabet Res Care 8(1): e001319

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!